| Investigator | Title | Sponsor | ID | Dates | Amount | 
        
            | Sharat Chandra, MD | IDF Severe Combined Immunodefi | Health Resources & Services Admin/University of California, San Francisco | 12689sc | 8/1/20-7/31/22 | $12,000 | 
        
            | Anthony J Sabulski, MD | Mechanisms and Consequences of | Thrasher Research Fund | Sabulski, Anthony, T | 1/1/22-12/31/22 | $12,039 | 
        
            | Kasiani C Myers, MD | Systems Biology of Bone Marrow | National Institutes of Health (NIH)/Children's Hospital Boston | GENFD0001792995 | 7/1/21-6/30/22 | $13,423 | 
        
            | Jacob Bleesing, MD-PHD | PRIMARY IMMUNE DEFICIENCY TREA | National Institutes of Health (NIH)/The Univ of California, San Francisco | 8404sc | 9/1/21-8/31/22 | $16,350 | 
        
            | Kasiani C Myers, MD | BMT CTN 1904 | National Institutes of Health (NIH)/National Marrow Donor Program | 1904 | 7/1/21-6/30/26 | $18,093 | 
        
            | Stella M Davies, MD | Molecular mechanisms for bone | National Institutes of Health (NIH)/Northwestern University Medical School | 60052734 CCHMC | 2/1/21-1/31/22 | $21,684 | 
        
            | Pooja Khandelwal, MD | Development and Psychometric T | National Institutes of Health (NIH)/Westat, Inc | 75N91020F00087 | 5/1/20-4/30/24 | $23,500 | 
        
            | Ruby Khoury, MD | A Multi-Center, Phase II Trial | National Marrow Donor Program | C10146 | 6/1/21-5/31/26 | $23,556 | 
        
            | Sharat Chandra, MD | Identifying Novel CSF Biomark | Histiocytosis Association of America | Chandra, S., HAA | 1/1/22-12/31/22 | $50,000 | 
        
            | Jeremy D Rubinstein, MD-PHD | Viral specific T-cells as anti | St. Baldrick's Foundation | Rubinstein, J., St. | 7/1/21-6/30/22 | $95,250 | 
        
            | Anthony J Sabulski, MD | Mechanisms and Markers of Graf | Hyundai Hope on Wheels | Sabulski, A., HHOW | 12/1/21-11/30/22 | $100,000 | 
        
            | Stella M Davies, MD | MIDAS: Microangiopathy, Endoth | National Institutes of Health (NIH)/The Ohio State University Research Fnd | 60078812 | 8/1/21-7/31/22 | $139,160 | 
        
            | Stella M Davies, MD | Childhood Cancer Survivor Study | National Institutes of Health (NIH)/St Jude's Children's Hospital | 111287260-7914878 | 12/1/20-11/30/21 | $152,707 | 
        
            | Stella M Davies, MD | Host and viral determinants of | National Institutes of Health (NIH)/Children's Hospital of Philadelphia | TBD | 7/1/21-6/30/22 | $285,783 | 
        
            | Stella M Davies, MD | Randomized trial of viral spec | National Institutes of Health (NIH) | U01AI157620 | 5/1/22-4/30/23 | $354,337.50 | 
        
            | Parinda Mehta, MD | Quercetin Chemoprevention for | Food and Drug Administration | R01FD006353 | 7/1/21-6/30/22 | $431,437 | 
        
            | Zackary Cleveland, PHD | Imaging and Molecular Phenotyp | National Institutes of Health (NIH) | RHL151588A | 2/3/21-1/31/22 | $562,685 | 
        
            | Assem Ziady, PHD | Commercial Translation of Biom | National Institutes of Health (NIH) | R61HL154105 | 12/1/21-7/31/23 | $572,829 | 
        
            | Sonata Jodele, MD | Thrombotic microangiopathy (TM | National Institutes of Health (NIH) | R01HD093773 | 9/1/21-8/31/23 | $674,875 | 
        
            | Stella M Davies, MD | TRANSPIRE: A Prospective Cohor | National Institutes of Health (NIH) | 1R01HL157392-01 | 9/1/21-5/31/22 | $742,257 | 
        
            | Assem Ziady, PHD | Predictive Molecular Markers o | National Institutes of Health (NIH) | R01HL142210 | 4/1/22-3/31/23 | $833,651 | 
        
            | Kasiani C Myers, MD | Penetrating the "Black box": | National Institutes of Health (NIH) | R01HL153108 | 5/1/22-4/30/23 | $1,269,671 | 
        
            | Total Annual Grant Award Dollars | $6,405,287.50 |